U.S. House · 117th Congress · H.R. 2855
Star Rating for Biosimilars Act
To amend title XVIII of the Social Security Act to require the Secretary of Health and Human Services to add a new set of measures to the 5-star rating system under the Medicare Advantage program in order to encourage increased access to biosimilar biological products.
Follow
Log in to follow this bill and get an email when there’s a new vote (premium).
- Sponsor
- Paul TonkoD-NY-20
- Introduced
- April 26, 2021, in the House
- Issue areas
- Policy area
- Health (from the Congressional Research Service)
- Full text and actions
- congress.gov
Votes on this bill (0)
Neither the House nor the Senate has held a roll-call vote on this bill.
Cosponsors (1)
1 Republican. Each member is shown with the party they were counted with on the day they signed on. How we count these
Original cosponsors
- Bob GibbsR-OH-7